CASR and familial hypocalciuric hypercalcemia: Similarly, inactivating mutations in the CASR gene are not only associated with familial hypocalcemic hypercalcaemia (FHH), but may also promote disease progression through abnormalities in calcium-sensitive receptor signaling pathways in sporadic PHPT (61, 62).